Business Wire

The PROSUME Energy Foundation Presents a Blockchain-Based Platform That Will Foster the Peer-to-Peer Energy Exchanges

Del

Rethinking the actual energy models, looking forward a network of communities and new ways to share sources: these are the ideas behind the Swiss PROSUME Energy Foundation, founded in Zug, the heart of the Crypto Valley, by professionals with a strong and long-time experience in the energy sector as well as in the blockchain softwares.

The Foundation has developed a new revolutionary platform to exchange electricity from renewable and fossil sources. It connects independent power producers, consumers, innovative utility companies and energy communities in a locally shared market where each peer is free to interact in a multi-tenant ecosystem.

The mission of the Foundation is to promote decentralizing power models and empower energy communities through the blockchain software technology and through the implementation of peer to peer energy exchange policies targeting possible solutions for all the existing physical and legal energy framework barriers, investing in Research & Development to offer innovative hardware and IoT-devices related to smart metering, smart grid, energy routers and devices.

PROSUME is based over 3 main pillars: decentralization, digitalization and decarbonisation. Blockchain has been considered the perfect tool to achieve the mission of the Foundation because this disruptive technology combines IT with cryptography and governance principles to create a new safer, more resilient and transparent place where everyone could be independent in choosing his own energy sources.

In order to support its project and mission, Prosume is launching a pre-ICO based on upgradeable ERC20 derivate Token named PEF Token on the Ethereum platform, the industry standard for issuing custom digital assets and smart contracts. Its ease in the use by everyone let Ethereum be the perfect solution for an Initial Coin Offering.

Because the platform deals with many of today’s problems and opportunities related to the energy sharing sector, like support for regulation frameworks, fair policy pricing, network balancing, smart payment and smart billing, the advanced features and active ecosystem of Ethereum make it the natural fit for Prosume. Ethereum’s ability to deploy smart contracts enables complex issuance rules for cryptocurrencies, digital financial contracts, and automated incentive structures.

“We strongly believe in the sharing energy model based on the peer to peer exchange system, for this reason PROSUME platform has as its main goal to be the most innovative place to develop energy communities, in order to give everyone the possibility to exchange energy in a more transparent, traceable, accessible, flexible, resilient and sustainable wayaffirms Alfredo Giardina, Co-founder of PROSUME Energy Foundation.

The pre-ICO will start on the 27th of September 2017, providing early adopters and strategic partners the chance to exchange tokens for ETH or BTC or LTC with a significant Bonus, starting at 47 %.
The main ICO will last for 4 weeks, with a different bonus rate every week limited to a certain size.

The ERC20 token interface allows for the deployment of a standard token that is compatible with the existing infrastructure of the Ethereum ecosystem, such as development tools, wallets, and exchanges.

The token accepted for the pre-ICO are ETH (ethereum) BTC (bitcoin) and LTC (litecoin).

The PEF Token will be upgradeable using an opt-in mechanism for future upgrades and it will be non-transferable until the ICO ends. The ICO contract will have a limit of 50000 PEF Tokens in order to facilitate a uniform ICO process. Multiple transactions are allowed.

Several energy companies from all around Europe have already showed a keen interest in this project and PROSUME is now negotiating eight different pilot projects. The upcoming pre-ICO will be the perfect opportunity to let everyone take active part to this great revolution. We really do believe in the power of sharing energy as this is the best way to empower yourself and gain your independence” continues Mr. Giardina.

Contact information

Prosume
Giovanni Quaglino
pressoffice@prosume.io

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers17.2.2018 21:00Pressemelding

Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im

CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 08:00Pressemelding

Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates

Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 18:26Pressemelding

Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a

General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 17:05Pressemelding

General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges

Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 09:03Pressemelding

Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o

Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 08:00Pressemelding

Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and